Related Experiment Videos
High dose chemotherapy in ovarian cancer
E Pujade-Lauraine1, H Curé, C Battista
1GINECO trials, Departement of Hematology and Medical Oncology, Hôtel-Dieu, Paris, France.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Maintenance of PARP Inhibitor Rechallenge plus Bevacizumab in Patients with Platinum-Sensitive, Recurrent Ovarian Cancer Previously Treated with a PARP Inhibitor.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Predictive value of BRCA1/RAD51C methylation in HGSOC - An ancillary study of the PAOLA-1/ENGOT-ov25 phase 3 trial.
European journal of cancer (Oxford, England : 1990)·2025
Dostarlimab and niraparib in primary advanced ovarian cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2025
Efficacy of subsequent therapies in patients with advanced ovarian cancer who relapse after first-line olaparib maintenance: results of the PAOLA-1/ENGOT-ov25 trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2024
Application of small-pelvic adjuvant radiotherapy in early cervical cancer without high-risk factors after hysterectomy.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026
Hormone replacement therapy in gynecologic cancer survivors: bridging the gap between evidence and clinical practice.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026
Integration of immuno-nutritional status into International Federation of Gynecology and Obstetrics risk stratification to predict chemotherapy response and survival in gestational trophoblastic neoplasia.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026
Clinical outcomes and prognostic factors in advanced high-grade platinum-resistant ovarian carcinoma: evidence from the ESME real-world cancer database.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026
Secondary cytoreduction for ovarian cancer relapse: results from the high surgical quality, multi-center "Surgery in Recurrent Ovarian Cancer Research Consortium (SURROC-CON)".
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026
Arterial embolization for hemorrhage control in gynecologic malignancies: a narrative review of current evidence and unresolved questions.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026
Intraoperative Hemodynamic Management and Cerebral Protection During Awake Craniotomy: Evidence-Based Approaches.
Anesthesiology research and practice·2026
Combined Enzyme-Responsive Nano-Peptide Drug with Photothermal Function for Effective Anti-Hepatocellular Carcinoma in Mice Model.
International journal of nanomedicine·2026
Pathologic Complete Response to Neoadjuvant Dual Checkpoint Blockade with Durvalumab Plus Tremelimumab in Advanced-Stage HCC: A Case Report.
Journal of hepatocellular carcinoma·2026